Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Phase 2
Completed
- Conditions
- Facial AngiofibromaTuberous Sclerosis
- Interventions
- Drug: placebo
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Dermatology Specialties Limited Partnership
- Target Recruit Count
- 107
- Registration Number
- NCT03826628
- Locations
- 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸University of California San Diego, La Jolla, California, United States
🇺🇸All Children's Research Institute, Saint Petersburg, Florida, United States
News
No news found